Pathway Choice Focus (NY) 4-Year with ROP review

It depends on your situation. For a New York resident with $100,000 or more to commit for four years who wants a guaranteed rate and no MVA risk, this is a reasonably solid choice. The ROP rider and Extended Care waiver add meaningful value. For a buyer with less than $100,000, the rate at the low band is modest and may not be compelling against other short-term fixed options. For anyone outside New York, this product simply is not available.

The clearest reason to choose this annuity is the combination of a guaranteed rate, no MVA, and an automatic return-of-premium rider — all in a 4-year commitment. New York has stricter insurance regulations than most states, which tends to produce slightly lower rates but also more conservative product structures. Buyers who prioritize certainty over yield and want to know their original deposit is protected even in early surrender scenarios will find the ROP feature meaningful. The product also works across qualified and nonqualified accounts, including IRA, Roth IRA, SEP IRA, and nonqualified.

I think this annuity is best for a New York resident in or near retirement who wants a short-term safe-money parking spot with a defined endpoint, no market exposure, and a guaranteed floor on what they get back if plans change. It is also appropriate for someone who has experienced the complexity of indexed products and wants something with no moving parts. It is less attractive for someone prioritizing maximum yield — the rates, while reasonable for a NY-market MYGA, are not at the top of the national fixed annuity market — and it is not the right fit for anyone outside New York.

You are buying a four-year guaranteed-rate insurance contract that credits a fixed interest rate, locks that rate until the end of the surrender period, and then either renews or allows you to walk away penalty-free. Unlike a bank CD, the interest grows tax-deferred inside the contract. Unlike many annuities, there is no market value adjustment clause, which means your surrender value will not swing based on interest rate movements. The return-of-premium rider is a meaningful contractual guarantee: even if you surrender early, the insurer is obligated to return at least your original premium, less any prior withdrawals. Surrender charges still apply to amounts above the free-withdrawal amount, but the ROP floor means you cannot walk away with less than your principal.

Pathway Choice Focus (NY) 4-Year with ROP is a single-premium deferred annuity that credits a fixed interest rate for the full four-year surrender period. The rate is tiered by deposit size: as of the brochure date (April 2026), the current guaranteed rates are 3.20% for deposits below $100,000, 4.00% for deposits of $100,000 to $249,999, and 4.05% for deposits of $250,000 or more. An updated rate schedule effective May 11, 2026 increased these to 3.30%, 4.10%, and 4.15% respectively. These rates are locked at issue for the full four years — they do not change with market conditions during the surrender period. There is no cap, no participation rate, and no index exposure. You know exactly what rate you are earning from day one.

The product accepts flexible premium deposits (FPDA) during the first 60 days after issue, which provides a modest window to add funds and potentially move up to a higher rate band after the initial purchase.

The return-of-premium rider is the defining secondary feature here, and it is included automatically at no additional cost. It guarantees that even if you surrender the contract before the end of the surrender period, you will receive at least your original premium back. This matters because it changes the risk profile of an early exit. Without an ROP feature, surrender charges on a conventional MYGA can reduce your payout below your original deposit in the early contract years — here, they cannot. For a buyer who is uncertain whether their timeline will hold, or who wants belt-and-suspenders certainty, the ROP rider provides a meaningful contractual safety net.

The Extended Care waiver adds a second layer of practical protection. If the annuitant becomes confined to a nursing facility or requires extended care, the surrender charges may be waived entirely. This is not a long-term care insurance product, but the waiver addresses the scenario where health needs force an early withdrawal.

The 4-year surrender period is a genuine commitment. Free withdrawals are limited to 10% of the previous Account Anniversary Value after year one, and the account must maintain a minimum balance of $2,000. Withdrawals above the free amount are subject to surrender charges of 7%, 6%, 5%, and 4% in years one through four respectively — a declining schedule that becomes more forgiving as you approach the end of the term.

Crucially, there is no market value adjustment on this product. That means your surrender value is not affected by movements in interest rates between now and when you exit — a meaningful structural advantage over MVA-bearing products in a rising-rate environment.

Required minimum distributions are confirmed as RMD-friendly. Terminal illness and Extended Care waivers may allow surrender charge-free access in qualifying health events. Even with these provisions, the product is designed around a four-year holding period and should only be funded with dollars you genuinely do not expect to need before maturity.

There are no explicit contract fees or rider fees on this product. No income rider is available, so there is no rider charge to evaluate. The return-of-premium rider is included at no additional cost. The Extended Care waiver is similarly included without a separate fee.

The main tradeoffs are structural. First, the rate at the low premium band (below $100,000) is noticeably lower than the mid and upper bands — nearly 80 basis points at current rates. Second, this is a NY-only product, which means it reflects New York's regulatory environment and pricing norms rather than the broader national market. NY-market MYGAs typically run somewhat lower in yield than comparable products sold nationally. Third, the product is purely fixed-rate with no opportunity to benefit from higher rates if the broader interest rate environment moves up during the surrender period.

Legal Entity: The United States Life Insurance Company in the City of New York

Parent: Corebridge Financial

A.M. Best Rating: A